{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:17:37Z","timestamp":1787584657650,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    This review synthesizes current knowledge on diagnostic, therapeutic, and management approaches for breast cancer, addressing both common and complex clinical scenarios. The analysis covers genetic predisposition in high-penetrance gene carriers, surgical interventions ranging from modified radical mastectomy to oncoplastic techniques, and diagnostic procedures such as sentinel lymph node biopsy. Specific clinical challenges are examined, including the presentation of metastatic disease, non-palpable lesion detection, ductal carcinoma\n                    <jats:italic toggle=\"yes\">in situ<\/jats:italic>\n                    management, and treatment strategies for locally advanced non-metastatic cases. Post-treatment surveillance protocols are evaluated in the context of evolving clinical guidelines. As the leading global malignancy in women, breast cancer continues to present substantial public health burdens and clinical decision-making complexities. The discussion highlights recent progress in early detection modalities, treatment innovations, and prevention methodologies, providing clinicians with evidence-based updates for risk stratification and personalized patient care.\n                  <\/jats:p>","DOI":"10.1097\/ms9.0000000000004002","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:00:09Z","timestamp":1760094009000},"page":"8400-8404","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Surgical management of breast cancer: a review"],"prefix":"10.1097","volume":"87","author":[{"given":"Suzita","family":"Hirachan","sequence":"first","affiliation":[{"name":"Department of General Surgery, Breast and Thyroid Unit, Tribhuvan University Teaching Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adheesh","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Breast and Thyroid Unit, Primera Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Khanal","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"R1-20260319","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/j.clbc.2024.02.011","article-title":"Exploring the oncogenic potential of TIMM8A: a crucial factor in breast cancer tumorigenesis","volume":"24","author":"Chi","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"R2-20260319","doi-asserted-by":"crossref","first-page":"2212\u201326","DOI":"10.1002\/ijc.33400","article-title":"Geospatial barriers to healthcare access for breast cancer diagnosis in sub-Saharan African settings: the african breast cancer-disparities in outcomes cohort study","volume":"148","author":"Togawa","year":"2021","journal-title":"Int J Cancer"},{"key":"R3-20260319","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.ctrv.2022.102339","article-title":"Global challenges and policy solutions in breast cancer control","volume":"104","author":"Trapani","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"R4-20260319","doi-asserted-by":"crossref","first-page":"497\u2013555","DOI":"10.1097\/00000658-189407000-00075","article-title":"The results of operations for the cure of cancer of the breast performed at the johns hopkins hospital from June, 1889, to January, 1894","volume":"20","author":"Halsted","year":"1894","journal-title":"Ann Surg"},{"key":"R5-20260319","first-page":"290\u2013303","article-title":"Breast cancer-major changes in the american joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R6-20260319","first-page":"100082","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN Guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R7-20260319","doi-asserted-by":"crossref","first-page":"1216\u201335","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Panelists of the St Gallen Consensus C: customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"R8-20260319","doi-asserted-by":"crossref","first-page":"66\u201371","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"R9-20260319","doi-asserted-by":"crossref","first-page":"440\u201351","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"key":"R10-20260319","doi-asserted-by":"crossref","first-page":"523\u201337","DOI":"10.1007\/s10549-018-4937-1","article-title":"Oncoplastic breast consortium consensus conference on nipple-sparing mastectomy","volume":"172","author":"Weber","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R11-20260319","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13053-020-00152-z","article-title":"Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation","volume":"18","author":"Mansfield","year":"2020","journal-title":"Hered Cancer Clin Pract"},{"key":"R12-20260319","doi-asserted-by":"crossref","first-page":"djw177","DOI":"10.1093\/jnci\/djw177","article-title":"Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kotsopoulos","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R13-20260319","doi-asserted-by":"crossref","first-page":"1547\u201353","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"R14-20260319","doi-asserted-by":"crossref","first-page":"77\u2013102","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R15-20260319","doi-asserted-by":"crossref","first-page":"761\u201374","DOI":"10.1038\/cr.2016.69","article-title":"RANKL\/RANK control Brca1 mutation","volume":"26","author":"Sigl","year":"2016","journal-title":"Cell Res"},{"key":"R16-20260319","doi-asserted-by":"crossref","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"R17-20260319","doi-asserted-by":"crossref","first-page":"441\u201352","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"R18-20260319","first-page":"CD000563","article-title":"Post-operative radiotherapy for ductal carcinoma in situ of the breast","volume":"2013","author":"Goodwin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20260319","doi-asserted-by":"crossref","first-page":"1528\u201329","DOI":"10.1245\/s10434-021-10552-7","article-title":"Surgical excision versus neoadjuvant radiotherapy followed by delayed surgical excision of ductal carcinoma In Situ (NORDIS)","volume":"29","author":"Rossi","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R20-20260319","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-015-1904-7","article-title":"Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis","volume":"15","author":"Stuart","year":"2015","journal-title":"BMC Cancer"},{"key":"R21-20260319","doi-asserted-by":"crossref","first-page":"360\u201372","DOI":"10.1016\/j.clbc.2021.02.012","article-title":"Long-term survival comparison of repeated breast-conserving surgery versus mastectomy for patients with DCIS with ipsilateral breast tumor recurrence: a real-world longitudinal study","volume":"21","author":"Li","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"R22-20260319","doi-asserted-by":"crossref","first-page":"5319\u201324","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern cooperative oncology group","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"key":"R23-20260319","doi-asserted-by":"crossref","first-page":"709\u201315","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"key":"R24-20260319","doi-asserted-by":"crossref","first-page":"2296\u2013303","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"key":"R25-20260319","doi-asserted-by":"crossref","first-page":"1497\u2013510","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"R26-20260319","first-page":"1027","article-title":"A prospective multicenter phase II study of endocrine therapy alone for endocrine-responsive ductal carcinoma in situ of the breast","volume":"21","author":"Sato","year":"2021","journal-title":"BMC Cancer"},{"key":"R27-20260319","doi-asserted-by":"crossref","first-page":"CT086","DOI":"10.1158\/1538-7445.AM2017-CT086","article-title":"Abstract CT086: Treatment of Ductal Carcinoma in Situ (DCIS) with Pasireotide, an IGF-I Inhibitor","volume":"77","author":"Illa-Bochaca","year":"2017","journal-title":"Cancer Res"},{"key":"R29-20260319","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"van Roozendaal","year":"2017","journal-title":"BMC Cancer"},{"key":"R30-20260319","doi-asserted-by":"crossref","first-page":"918\u201326","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"Jama"},{"key":"R31-20260319","doi-asserted-by":"crossref","first-page":"1385\u201393","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"R32-20260319","doi-asserted-by":"crossref","first-page":"1303\u201310","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"R33-20260319","doi-asserted-by":"crossref","first-page":"678\u201381","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European institute of oncology of milan (SOUND: sentinel node vs observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"R34-20260319","first-page":"2763\u201372","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: first results of the prospective multicenter INSEMA trial","volume":"39","author":"Reimer","year":"2021","journal-title":"J Clin Oncol"},{"key":"R35-20260319","first-page":"TPS597","article-title":"Non-inferiority of omission of sentinel node procedure in breast cancer patients with adequate response to neoadjuvant systemic therapy: a randomized controlled trial. The BOOG 2013-08 SOUND study","volume":"36","author":"Tinteren","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:04:02Z","timestamp":1773936242000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004002","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"2025-04-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}